(Alliance News) - AstraZeneca PLC on Sunday announced results from the phase 3 trial of its Baxdrostat treatment which showed a statistically significant reduction in the systolic blood pressure of patients with resistant hypertension. Read More
(Alliance News) - The FTSE 100 fell on Thursday as the Bank of England left interest rates unchanged in a tight vote and investors weighed a deluge of earnings from leading blue-chip names. Read More
(Alliance News) - Stock prices in London opened steady on Thursday amid a delude of earnings, as investors focus on a finely balanced interest rate decision from the Bank of England. Read More
(Alliance News) - AstraZeneca PLC on Thursday said a strong performance in 2025 so far, with third quarter sales ahead of forecast, leaves it well-placed to sustain growth through 2026. Read More
(Alliance News) - AstraZeneca reports higher earnings, J Sainsbury raises its profit guidance and interim dividend while ITV warns of a tough advertising market. Read More
(Alliance News) - Hutchmed China Ltd on Wednesday said patient enrolment has been completed for its phase 3 Saffron trial evaluating the combination of Orpathys and Tagrisso in certain lung cancer patients, with topline results expected in the first half of 2026. Read More
(Alliance News) - The FTSE 100 outperformed European and US peers on Tuesday, but sterling fell further, as Chancellor Rachel Reeves laid the groundwork for further tax rises in this month’s budget. Read More
(Alliance News) - AstraZeneca PLC on Thursday said phase 3 data regarding its investigational inhibitor gefurulimab met its primary endpoint in myasthenia gravis activities of daily living. Read More
(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Friday said they began new phase 3 clinical trial testing of an intravenous treatment for advanced lung cancer. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said Alexion's selective inhibitor Koseluga has been approved in the EU for the treatment of symptomatic, inoperable plexiform neurofibromas, PN, in adult patients with neurofibromatosis type 1, NF 1. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said its drug Tezspire has been approved in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps. Read More
(Alliance News) - AstraZeneca PLC on Monday said its lupus drug Saphnelo received a positive opinion from the European Medicines Agency's committee for medicinal products for human use for a new subcutaneous formulation. Read More
(Alliance News) - B&M European Value Retail cuts its profit guidance following an accounting error and says Chief Financial Officer Mike Schmidt will step down, while Bank of Ireland and Secure Trust Bank may increase provisions linked to the UK motor finance redress scheme. AstraZeneca announces a drug approval in the US. Read More
